PRONIRAS
Proniras Corp is an operator of a biomedical company intended to develop drugs. The company's biomedical service has already demonstrated preclinical efficacy in treating nerve agent-induced seizures, as well as in studies of rodents exposed to the chemical weapon soman, which is more toxic than sarin gas, enabling medical researchers to continue their research work and discover drugs. It was founded in 2016 and is headquartered in Seattle, Washington.
PRONIRAS
Social Links:
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2016-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.proniras.com
Total Employee:
1+
Status:
Active
Contact:
206-957-7300
Email Addresses:
[email protected]
Total Funding:
13.25 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Tag Manager WordPress Google Maps LetsEncrypt SSL By Default Global Site Tag Apache
Similar Organizations
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
WRF Capital
WRF Capital investment in Series B - Proniras
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Proniras
Accelerator Life Science Partners
Accelerator Life Science Partners investment in Series B - Proniras
Watson Fund
Watson Fund investment in Series B - Proniras
Accelerator Life Science Partners
Accelerator Life Science Partners investment in Venture Round - Proniras
Official Site Inspections
http://www.proniras.com
- Host name: gra.graphicainc.com
- IP address: 162.241.142.33
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Proniras"
Proniras
2815 Eastlake Ave E., Suite 300 Seattle, WA 98102 T: 206-957-7300 F: 206-957-7399See details»
Overview - Proniras
Proniras Corporation (“Proniras”) is a clinical-stage biotechnology company focused on the …See details»
Proniras - Crunchbase Company Profile & Funding
Proniras Corp is an operator of a biomedical company intended to develop drugs. The …See details»
Proniras Company Profile 2024: Valuation, Funding & Investors
Proniras has raised $8.9M. Who are Proniras’s investors? National Institute on Drug Abuse …See details»
Proniras - Org Chart, Teams, Culture & Jobs - The Org
Proniras Corporation is a preclinical-stage biotech company focused on the development of a …See details»
Proniras - Overview, News & Similar companies | ZoomInfo.com
Proniras was founded in 2017 by Accelerator Life Science Partners and Christopher Toombs, …See details»
Proniras Corporation Company Profile | Seattle, WA | Competitors ...
Find company research, competitor information, contact details & financial data for Proniras …See details»
Proniras Company Profile - Office Locations, Competitors ... - Craft
Proniras has 5 employees at their 1 location and $2.8 m in total funding,. See insights on …See details»
Proniras - Funding, Financials, Valuation & Investors - Crunchbase
Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat …See details»
Proniras - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Proniras . Connect to CRM . Save . Summary. Financials. People. Technology. …See details»
Proniras - VentureRadar
Proniras Corporation is a Seattle-based biopharmaceutical company focused on developing …See details»
Proniras – Accelerator
Proniras Corporation is a clinical-stage biotechnology developing novel small-molecule …See details»
Development Programs - Proniras
2815 Eastlake Ave E., Suite 300 Seattle, WA 98102 T: 206-957-7300 F: 206-957-7399See details»
Proniras Corporation Secures New Series B Financing and
SEATTLE--(BUSINESS WIRE)-- Proniras Corporation (“Proniras”), a clinical-stage …See details»
Series B - Proniras - 2024-02-01 - Crunchbase
Organization Name . Proniras . Announced Date Feb 1, 2024; Funding Type Series B; Funding …See details»
Proniras Corporation Secures New Series B Financing and Names …
Seattle, WA — February 01, 2024, Proniras Corporation (“Proniras”), a clinical-stage …See details»
Proniras Corporation Announces National Institute on Drug Abuse …
Proniras Corporation is a Seattle-based biotechnology company focused on developing …See details»
Proniras launches with BARDA funding to pit migraine drug …
Proniras, based in Seattle, licensed the exclusive global rights to tezampanel (LY-293,558) …See details»
Proniras: $4.65 Million Funding Raised To Develop Small-Molecule ...
Proniras Corporation - a clinical-stage biotechnology company developing novel small …See details»
Our Pipeline - Proniras
2815 Eastlake Ave E., Suite 300 Seattle, WA 98102 T: 206-957-7300 F: 206-957-7399See details»